115 Mortality rates for breakthrough invasive fungal infections in a multicenter trial of posaconazole vs standard azole prophylaxis

D.J.Winston; O.A.Cornely; J.Maertens; J.Perfect; D.D.Helfgott; A.J.Ullmann; J.Holowiecki; D.Stockelberg; Y.-T.Goh; M.Petrini; T.J.Walsh; C.Hardalo; D.Angulo-Gonzalez

首页> 外文期刊>International journal of infectious diseases : >115 Mortality rates for breakthrough invasive fungal infections in a multicenter trial of posaconazole vs standard azole prophylaxis

【24h】

115 Mortality rates for breakthrough invasive fungal infections in a multicenter trial of posaconazole vs standard azole prophylaxis

机译：115泊沙康唑与标准唑预防的多中心试验中突破性侵袭性真菌感染的死亡率

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《International journal of infectious diseases :》 |2006年第1期|共2页
作者
D.J.Winston; O.A.Cornely; J.Maertens; J.Perfect; D.D.Helfgott; A.J.Ullmann; J.Holowiecki; D.Stockelberg; Y.-T.Goh; M.Petrini; T.J.Walsh; C.Hardalo; D.Angulo-Gonzalez;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类传染病;
关键词

相似文献

外文文献
中文文献
专利

1. Economic Evaluation of Posaconazole Versus Standard Azole Therapy as Prophylaxis against Invasive Fungal Infections in Patients with Prolonged Neutropenia in Canada [J] . Amir A Tahami Monfared Amy K O’Sullivan Coleman Rotstein, George Papadopoulos Canadian Journal of Infectious Diseases and Medical Microbiology: Journal Canadien des Maladies Infectieuses . 2012,第6期

机译：泊沙康唑与标准唑治疗对预防中性粒细胞减少症患者的侵袭性真菌感染的经济评价
2. Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study [J] . Jutta Auberger12* Cornelia Lass-Flörl3 Maria Aigner3 Johannes Clausen12 Günther Gastl2 and David Nachbaur2 Journal of Antimicrobial Chemotherapy . 2012,第9期

机译：接受泊沙康唑预防性真菌治疗的高危患者的侵袭性真菌突破性感染，真菌定植和耐药菌株的出现：来自单中心机构回顾性观察研究的真实数据
3. Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: Real-life data from a single-centre institutional retrospective observational study [J] . AubergerJ., Lass-Fl?rlC., AignerM., The Journal of Antimicrobial Chemotherapy . 2012,第9期

机译：接受泊沙康唑预防性真菌治疗的高危患者的侵袭性真菌突破性感染，真菌定植和耐药菌株的出现：来自单中心机构回顾性观察研究的真实数据
4. A Multivariate Regression Model Of Mortality Associated With Fungal Infections In Pediatric Burn Patients [C] . F. Emdad, L. K. Branski, C. D. Djukom, World Multi-Conference on Systemics, Cybernetics and Informatics . 2009

机译：儿科烧伤患者真菌感染相关的多元回归模型
5. Development of Vaccines for Invasive Fungal Infections [D] . Rayens, Emily. 2021

机译：侵袭性真菌感染疫苗的开发
6. Economic evaluation of posaconazole versus standard azole therapy as prophylaxis against invasive fungal infections in patients with prolonged neutropenia in Canada [O] . Amir A Tahami Monfared, Amy K O’Sullivan, Coleman Rotstein, 2012

机译：加拿大泊沙康唑与标准唑治疗预防中性粒细胞减少症长期患者侵袭性真菌感染的经济评价
7. 115 Mortality rates for breakthrough invasive fungal infections in a multicenter trial of posaconazole vs standard azole prophylaxis [O] . Winston D.J., Cornely O.A., Maertens J., 2006

机译：115泊沙康唑与标准唑预防的多中心试验中突破性侵袭性真菌感染的死亡率

115 Mortality rates for breakthrough invasive fungal infections in a multicenter trial of posaconazole vs standard azole prophylaxis

著录项

相似文献

相关主题

期刊订阅